Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 14, 2026, 8:48 PM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 1–24 of 1,386 matching trials from the live ClinicalTrials.gov search.

Filters: Sponsor: Indiana University Clear all

Conditions: Free Flap Reconstruction
Interventions: sufentanil, methadone; Drug
Lead sponsor: Indiana University; Other
Eligibility: 18 Years to 80 Years
Enrollment: 128 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2027
U.S. locations: 1
States / cities: Indianapolis, Indiana

Conditions: Massage
Interventions: Quantifiable Soft Tissue Manipulation (QSTM); Device
Lead sponsor: Indiana University; Other
Eligibility: 18 Years to 75 Years
Enrollment: 106 participants
Timeline: 2021 – 2022
U.S. locations: 1
States / cities: Indianapolis, Indiana

Conditions: Hepatocellular Carcinoma
Interventions: Sorafenib, Stereotactic radiotherapy; Drug · Radiation
Lead sponsor: Indiana University; Other
Eligibility: 18 Years and older
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2012 – 2014
U.S. locations: 1
States / cities: Indianapolis, Indiana

Conditions: Arthritis, Rheumatoid, Vitamin D Deficiency
Interventions: Placebo in arm A and Vitamin D in arm B, vitamin D 3 for arm A ,and matching placebo for arm B; Drug
Lead sponsor: Indiana University; Other
Eligibility: 18 Years and older
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2009 – 2011
U.S. locations: 1
States / cities: Indianapolis, Indiana

Conditions: Thoracotomy, Pain, Postoperative
Interventions: Gabapentin; Drug
Lead sponsor: Indiana University; Other
Eligibility: 18 Years to 70 Years
Enrollment: 20 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2022
U.S. locations: 1
States / cities: Indianapolis, Indiana

Conditions: Prostate Cancer Recurrent
Interventions: Low protein diet, Control protein diet; Other
Lead sponsor: Indiana University; Other
Eligibility: 18 Years and older · Male only
Enrollment: 2 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2017 – 2020
U.S. locations: 2
States / cities: Indianapolis, Indiana

Conditions: Metastatic Breast Cancer, Leptomeningeal Disease
Interventions: Tucatinib, Trastuzumab, Capecitabine; Drug
Lead sponsor: University of Alabama at Birmingham; Other
Eligibility: 18 Years and older
Enrollment: 17 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019 – 2021
U.S. locations: 9
States / cities: Birmingham, Alabama • San Francisco, California • Washington D.C., District of Columbia + 6 more

Conditions: Pain, Amputation Neuroma, Amputation
Interventions: Digital nerve procedure; Procedure
Lead sponsor: Indiana University; Other
Eligibility: 18 Years and older
Enrollment: 39 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020 – 2023
U.S. locations: 1
States / cities: Indianapolis, Indiana

Conditions: Type 1 Diabetes, Adolescent Behavior
Interventions: Mind-body skills, Diabetes education; Behavioral
Lead sponsor: Indiana University; Other
Eligibility: 15 Years to 17 Years
Enrollment: 30 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2024
U.S. locations: 2
States / cities: Indianapolis, Indiana

Conditions: Recurrent Acute Pancreatitis
Interventions: Biliary sphincterotomy, Pancreatobiliary sphincterotomy, Sham; Procedure
Lead sponsor: Indiana University; Other
Eligibility: 18 Years and older
Enrollment: 89 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 1997 – 2014
U.S. locations: 1
States / cities: Indianapolis, Indiana

Conditions: Type 1 Diabetes
Interventions: Difluoromethylornithine, Placebo; Drug
Lead sponsor: Indiana University; Other
Eligibility: 12 Years to 40 Years
Enrollment: 41 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2015 – 2020
U.S. locations: 3
States / cities: Indianapolis, Indiana • Buffalo, New York • Wauwatosa, Wisconsin

Conditions: Type1diabetes, Diabetes Mellitus, Type 1, Type1 Diabetes Mellitus, Diabetes Mellitus
Interventions: Blood Collection; Other
Lead sponsor: Medical College of Wisconsin; Other
Eligibility: 2 Years and older
Enrollment: 4,000 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2001 – 2050
U.S. locations: 1
States / cities: Milwaukee, Wisconsin

Conditions: Human Papillomavirus Vaccination
Interventions: Not listed
Lead sponsor: Indiana University; Other
Eligibility: 13 Years to 17 Years
Enrollment: 62 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2011 – 2012
U.S. locations: 1
States / cities: Indianapolis, Indiana

Conditions: Intrauterine Device (IUD), Abnormal Uterine Bleeding
Interventions: Carevix, Tenaculum; Device
Lead sponsor: Indiana University; Other
Eligibility: 18 Years and older · Female only
Enrollment: 73 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2023 – 2024
U.S. locations: 1
States / cities: Indianapolis, Indiana

Conditions: Asthenopia, Myopia
Interventions: Contact lens with Multifocal Optics, Contact lens with Single Vision Optics; Device
Lead sponsor: Pete Kollbaum, OD, PhD; Other
Eligibility: 18 Years to 35 Years
Enrollment: 45 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2018
U.S. locations: 1
States / cities: Bloomington, Indiana

Conditions: Surgical Wound Infection, Cesarean Section
Interventions: Prophylactic NPWT, Standard Dressing; Device
Lead sponsor: Indiana University; Other
Eligibility: 16 Years and older · Female only
Enrollment: 1,624 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2017 – 2019
U.S. locations: 6
States / cities: Birmingham, Alabama • Indianapolis, Indiana • New Orleans, Louisiana + 1 more

Conditions: Traumatic Brain Injury
Interventions: Group Interactive Structured Treatment, Alternative Intervention; Behavioral
Lead sponsor: Craig Hospital; Other
Eligibility: 18 Years and older
Enrollment: 231 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2012 – 2015
U.S. locations: 6
States / cities: Palo Alto, California • Englewood, Colorado • Indianapolis, Indiana + 3 more

Conditions: Human Papilloma Virus Infection Type 11, Human Papilloma Virus Infection Type 16, Human Papilloma Virus Infection Type 18, Human Papilloma Virus Infection Type 6, Cervical Cancer, Genital Warts, Oropharyngeal Cancer
Interventions: Simple Reminder; Behavioral
Lead sponsor: Regenstrief Institute, Inc.; Other
Eligibility: 11 Years to 17 Years
Enrollment: 1,305 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2015 – 2016
U.S. locations: 5
States / cities: Indianapolis, Indiana

Conditions: Vapors; Inhalation, Cancer, Volatile Organic Compounds
Interventions: Environmental educational campaign; Behavioral
Lead sponsor: Purdue University; Other
Eligibility: 18 Years to 99 Years
Enrollment: 510 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2028
U.S. locations: 1
States / cities: West Lafayette, Indiana

Conditions: Alcoholic Hepatitis
Interventions: F-652; Drug
Lead sponsor: Mayo Clinic; Other
Eligibility: 21 Years and older
Enrollment: 18 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2016 – 2018
U.S. locations: 1
States / cities: Rochester, Minnesota

Conditions: Prediabetes, Cystic Fibrosis (CF), Cystic Fibrosis-related Diabetes
Interventions: CGM Dynamic Index (CDI); Device
Lead sponsor: Indiana University; Other
Eligibility: 12 Years to 55 Years
Enrollment: 14 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2026
U.S. locations: 1
States / cities: Indianapolis, Indiana

Conditions: Transient Ischemic Attack, Stroke
Interventions: Standard CPAP Intervention, Enhanced CPAP Intervention; Device · Behavioral
Lead sponsor: Yale University; Other
Eligibility: 18 Years and older
Enrollment: 255 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2011 – 2014
U.S. locations: 2
States / cities: New Haven, Connecticut • Indianapolis, Indiana

Conditions: Concussion, Mild, Concussion, Brain, Concussion, Severe, Concussion, Intermediate, Concussion; Syndrome, Concussion Injury of Cerebrum, Concussion with Brief Loss of Consciousness, Alexithymia
Interventions: Treatment; Behavioral
Lead sponsor: Indiana University; Other
Eligibility: 18 Years and older
Enrollment: 40 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2025
U.S. locations: 1
States / cities: Indianapolis, Indiana

Conditions: Sleep Hygiene, Inadequate
Interventions: Problematic bedtime media use counseling, Sleep problem counseling; Other
Lead sponsor: Indiana University; Other
Eligibility: 2 Years to 18 Years
Enrollment: 60,100 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2017 – 2019
U.S. locations: 2
States / cities: Indianapolis, Indiana

Search by objective public record fields.

Sufentanil Infusion vs Intravenous Methadone for Postoperative Analgesia Following Head and Neck Dissection With Free Flap or Rotational Reconstruction

The Reproducibility and Consistency of Instrument-assisted Soft Tissue Manipulation

A Phase Ib Study of Stereotactic Body Radiotherapy (SBRT) Plus Sorafenib in Patients With Unresectable Hepatocellular Carcinoma (HCC)

Vitamin D Deficiency Causes Immune Dysfunction and Enables or Perpetuates the Development of Rheumatoid Arthritis

Gabapentin Dosages for Postoperative Analgesia Following Open Thoracotomy

Sipuleucel-T and Low-protein Diet in Patients With Metastatic Castrate-resistant Prostate Cancer

Tucatinib, Trastuzumab, and Capecitabine for the Treatment of HER2+ LMD

Pain After Proximal Digital Amputation Prevention

Incorporating Mind-body Skills With Diabetes Education in Adolescents With Type 1 Diabetes

ERCP in Idiopathic Recurrent Acute Pancreatitis

DFMO in Children With Type 1 Diabetes

Genetics Of Autoimmunity In Type I Diabetes

Parent-son-provider Decision-making About HPV Vaccination

Suction Cervical Stabilizer Compared to Standard Tenaculum for Intrauterine Procedures

The Impact of Soft Contact Lens Attributes on Symptoms Associated With Digital Eye Strain in Symptomatic Soft Contact Lens Wearers

Preventing Adverse Incisional Outcomes at Cesarean Multicenter Trial

Treatment of Social Competence After Traumatic Brain Injury

HPV Vaccination: Evaluation of Reminder Prompts for Doses 2 & 3

Addressing Tetrachloroethylene Exposure in an Impacted Community

Use of F-652 in Patients With Alcoholic Hepatitis

CGM Dynamic Index for Predicting Prediabetes in Cystic Fibrosis

Sleep Apnea in TIA/Stroke: Reducing Cardiovascular Risk With Positive Airway Pressure

Building Emotional Self-Awareness Teletherapy (BEST)

Health Information Technology to Improve Bedtime Media Use in Children